| Trial registration number
|
NCT04992182 |
Full text link
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04992182
|
First author
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Rafael Araos
|
Contact
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
2021-08-05
|
Recruitment status
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Not recruiting
|
Study design
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
multi-center
|
Study aim
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- full immunization with coronavac (2 doses; 0,28) prior to april 15, 2021
- being a resident of any of the eligible nursing homes (located in the metropolitan
region of chile)
- healthcare workers of one of the eligible nursing homes.
- healthcare workers of hospital de urgencia asistencia publica (huap, santiago, chile)
|
Exclusion criteria
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
- prior history of covid-19
- not able to consent
|
Number of arms
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
4
|
Funding
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Universidad del Desarrollo
|
Inclusion age min
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Chile
|
Type of patients
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
534
|
primary outcome
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Early humoral response;Immunogenicity
|
Notes
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
Phase 2
|
Arms
Last imported at : Aug. 6, 2021, 3 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 327, "treatment_name": "Coronavac", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|